<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
                        <id>https://www.health.harvard.edu/authors/amy-ship-md/feed/atom</id>
                                <link href="https://www.health.harvard.edu/authors/amy-ship-md/feed/atom" rel="self"></link>
                                                    <title><![CDATA[Harvard Health Posts by Amy Ship, MD Feed]]></title>
                                <logo>https://www.health.harvard.edu/img/logos/hhp-logo-mark-lg.jpg</logo>
                                <image_height>173</image_height>
                                <image_width>144</image_width>
                                <subtitle>Harvard Health Blog: You'll find posts from Harvard Medical School physicians and our editors on a variety of health news and issues.</subtitle>
                                                    <updated>2015-09-21T12:00:26-04:00</updated>
                        <entry>
            <title><![CDATA[Turning to drugs and treatments before they are “ready for prime time”]]></title>
            <link rel="alternate" href="https://www.health.harvard.edu/blog/turning-to-drugs-and-treatments-before-they-are-ready-for-prime-time-201509218324" />
            <id>https://www.health.harvard.edu/blog/turning-to-drugs-and-treatments-before-they-are-ready-for-prime-time-201509218324</id>
                                            <author>
                    <name><![CDATA[Amy Ship, MD]]></name>
                </author>
                                        <summary type="html">
                <![CDATA[Having a terminal illness or debilitating disease is devastating. Imagine, then, being in that situation and exhausting the available treatment options — or having limited options to begin with. It’s understandable that people in these circumstances might welcome the opportunity to try experimental drugs or treatments. But it is not always easy or expedient to gain access to such therapies. So called “right-to-try” laws are supposed to help doctors and patients access these treatments. However, it isn’t clear that right-to-try laws will actually help, and they can create additional dilemmas in what are already complicated situations.]]>
            </summary>
            
                        <updated>2015-09-21T12:00:26-04:00</updated>
        </entry>
    </feed>
